Literature DB >> 11083684

Applying a prediction rule to identify low-risk patients with community-acquired pneumonia.

T K Marras1, C Gutierrez, C K Chan.   

Abstract

STUDY
OBJECTIVES: To study the validity of a recently developed community-acquired pneumonia (CAP) severity prediction rule in estimating mortality, to determine its utility in decision making regarding hospitalization, and to assess factors influencing this decision.
DESIGN: Retrospective chart review.
SETTING: Two sites of the University Health Network, the Toronto General and Toronto Western Hospitals, tertiary-care teaching institutions with a sizable primary-care and secondary-care source of referrals, and a total of 900 beds. PATIENTS: Consecutive patients with CAP admitted between February and June 1996. MEASUREMENTS AND
RESULTS: A single trained medical records extractor assembled data to compare our population to that used in developing the CAP prediction rule, in terms of mortality and to assess reasons for hospitalization. Two hundred fifty-five eligible patients were admitted, and 244 charts (96%) were available. Our patients tended to be older, with nearly four times as many residents of chronic care institutions (39% compared with 10%), and had a higher risk class distribution than the published cohort. Risk class-specific mortality was similar in four of five classes. Of the 71 patients in the low-risk classes, 67 had additional reasons for admission; 18 of which were psychosocial (homelessness, substance abuse, or inadequate home supports).
CONCLUSIONS: The CAP severity prediction rule estimates mortality well. Admission of low-risk patients was linked to psychosocial and other medical reasons not captured by this rule. The rule can be very useful in assessing the need for hospitalization; however, there remains a significant percentage of patients with a low severity score who may require hospitalization for psychosocial and economic considerations.

Entities:  

Mesh:

Year:  2000        PMID: 11083684     DOI: 10.1378/chest.118.5.1339

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  14 in total

1.  Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults.

Authors:  Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2007-03-01       Impact factor: 9.079

2.  Hospital admission decision for patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Paola Faverio; Francesco Blasi
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

3.  Factors associated with the hospitalization of low-risk patients with community-acquired pneumonia in a cluster-randomized trial.

Authors:  Jose Labarere; Roslyn A Stone; D Scott Obrosky; Donald M Yealy; Thomas P Meehan; Thomas E Auble; Jonathan M Fine; Louis G Graff; Michael J Fine
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

4.  Discharge Delay in Patients with Community-acquired Pneumonia Managed on a Critical Pathway.

Authors:  Jeremy J Moeller; Martin Ma; Paul Hernandez; Thomas Marrie; Claire Touchie; Ward Patrick
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-03       Impact factor: 2.471

Review 5.  Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia.

Authors:  Brad Spellberg; George H Talbot; Eric P Brass; John S Bradley; Helen W Boucher; David N Gilbert
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

6.  Predicting mortality with pneumonia severity scores: importance of model recalibration to local settings.

Authors:  P Schuetz; M Koller; M Christ-Crain; E Steyerberg; D Stolz; C Müller; H C Bucher; R Bingisser; M Tamm; B Müller
Journal:  Epidemiol Infect       Date:  2008-02-27       Impact factor: 2.451

7.  Xuebijing injection in the treatment of severe pneumonia: study protocol for a randomized controlled trial.

Authors:  Ping Wang; Yuanlin Song; Zhi Liu; Hui Wang; Wenke Zheng; Si Liu; Zhiqiao Feng; Jingbo Zhai; Chen Yao; Ming Ren; Chunxue Bai; Hongcai Shang
Journal:  Trials       Date:  2016-03-17       Impact factor: 2.279

8.  Etiological Diagnosis of Community-Acquired Pneumonia in Adult Patients: A Prospective Hospital-Based Study in Mashhad, Iran.

Authors:  Hamidreza Naderi; Fereshte Sheybani; Mohammadreza Sarvghad; Zahra Meshkat; Mehdi Jabbari Nooghabi
Journal:  Jundishapur J Microbiol       Date:  2015-08-29       Impact factor: 0.747

9.  Soluble form of suppression of tumorigenicity-2 predicts clinical stability of inpatients with community-acquired pneumonia.

Authors:  Yifeng Zeng; Mingshan Xue; Teng Zhang; Shixue Sun; Runpei Lin; Ning Li; Peiyan Zheng; Yingjie Zhen; Haisheng Hu; Xiaohua Douglas Zhang; Baoqing Sun
Journal:  Exp Biol Med (Maywood)       Date:  2021-07-05

10.  Determinants for hospitalization in " low-risk" community acquired pneumonia.

Authors:  Zakari Y Aliyu; Muktar H Aliyu; Ken McCormick
Journal:  BMC Infect Dis       Date:  2003-06-17       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.